These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11347742)

  • 1. Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients.
    Chern JP; Lin KH; Lu MY; Lin DT; Lin KS; Chen JD; Fu CC
    Diabetes Care; 2001 May; 24(5):850-4. PubMed ID: 11347742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
    Khalifa AS; Salem M; Mounir E; El-Tawil MM; El-Sawy M; Abd Al-Aziz MM
    Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection.
    Mowla A; Karimi M; Afrasiabi A; De Sanctis V
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():282-4. PubMed ID: 16462712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose Homeostasis and Effect of Chelation on β Cell Function in Children With β-Thalassemia Major.
    Gomber S; Dabas A; Bagmar S; Madhu SV
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):56-59. PubMed ID: 29200160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and morbidity in transfusion-dependent thalassemic patients on subcutaneous desferrioxamine chelation. Nearly two decades of experience.
    Calleja EM; Shen JY; Lesser M; Grady RW; New MI; Giardina PJ
    Ann N Y Acad Sci; 1998 Jun; 850():469-70. PubMed ID: 9668587
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin and glucagon responses to provocation with glucose and arginine in prepubertal children with thalassemia major before and after long-term blood transfusion.
    Soliman AT; el Banna N; alSalmi I; Asfour M
    J Trop Pediatr; 1996 Oct; 42(5):291-6. PubMed ID: 8936961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy.
    Jaruratanasirikul S; Chareonmuang R; Wongcharnchailert M; Laosombat V; Sangsupavanich P; Leetanaporn K
    Eur J Pediatr; 2008 Aug; 167(8):873-6. PubMed ID: 17899188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HBV and HCV among the multi-transfused beta thalassemic major patients in a day care centre of blood transfusion department of Mymensingh Medical College Hospital.
    Chakrabarty P; Rudra S; Hossain MA
    Mymensingh Med J; 2014 Apr; 23(2):235-41. PubMed ID: 24858148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.
    Gamberini MR; Fortini M; Gilli G; Testa MR; De Sanctis V
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():867-9. PubMed ID: 10091159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major.
    Suvarna J; Ingle H; Deshmukh CT
    Indian Pediatr; 2006 May; 43(5):393-400. PubMed ID: 16735760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary functions in Egyptian children with transfusion-dependent β-thalassemia.
    Abd El Hakeem AA; Mousa SMO; AbdelFattah MT; AbdelAziz AO; Abd El Azeim SS
    Transfus Med; 2019 Feb; 29(1):55-60. PubMed ID: 30779248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia.
    Chern JP; Lin KH
    J Pediatr Hematol Oncol; 2002 May; 24(4):291-3. PubMed ID: 11972098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study.
    Mirmomen S; Alavian SM; Hajarizadeh B; Kafaee J; Yektaparast B; Zahedi MJ; Zand V; Azami AA; Hosseini MM; Faridi AR; Davari K; Hajibeigi B
    Arch Iran Med; 2006 Oct; 9(4):319-23. PubMed ID: 17061602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of glucose intolerance and diabetes in transfused patients with thalassemia.
    Kattamis C; Ladis V; Tsoussis D; Kaloumenou I; Theodoridis C
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():267-71. PubMed ID: 16462709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.
    Gamberini MR; Fortini M; De Sanctis V; Gilli G; Testa MR
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():285-91. PubMed ID: 16462713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of iron overload and glomerular filtration rate estimated by cystatin C in patients with β-thalassemia major.
    Al-Khabori M; Bhandari S; Al-Rasadi K; Mevada S; Al-Dhuhli H; Al-Kemyani N; Daar S
    Hemoglobin; 2014; 38(5):365-8. PubMed ID: 25074643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients.
    Mansour AK; Aly RM; Abdelrazek SY; Elghannam DM; Abdelaziz SM; Shahine DA; Elmenshawy NM; Darwish AM
    Hematol Oncol Stem Cell Ther; 2012; 5(1):54-9. PubMed ID: 22446611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications.
    Farmaki K; Tzoumari I; Pappa C
    Blood Cells Mol Dis; 2011 Jun; 47(1):33-40. PubMed ID: 21531154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.